Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias

Sponsor
Tao Zhang (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05922605
Collaborator
(none)
44
1
2
22.4
2

Study Details

Study Description

Brief Summary

Caudal analgesia with ropivacaine is commonly used in sub-umbilical pediatric surgery. However, increasing the dosage of ropivacaine has not been found to prolong the action significantly while complications will be serious.

Ketamine as an additive to caudal administration had been shown to prolong the duration of postoperative analgesia, while the analgesic effectiveness of S-ketamine, the S(+)-enantiomer of ketamine with less possibility to induce psychomotor disturbances, is not clear. In this prospective randomized double-blind clinical trial , the investigators aimed to study the effect of S-ketamine as additive on the duration of caudal analgesia.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Forty-four children scheduled for hypospadias randomize into 2 groups. Group S (n=22) (0.2% ropivacaine 1 ml/kg and S-ketamine 0.5 mg/kg), group C(n=22)( 0.2%ropivacaine 1ml/kg and equivalent saline) intraoperative and postoperative hemodynamics will be recorded. Postoperative pain is assessed using an established 15-item Parents' Postoperative Pain Measure (PPPM) at 1h,3h,6h,12h,24h,48h, or the time when children complain of pain after surgery. A score of more than 6 points is taken as an indication of inadequate analgesia and paracetamol 15 mg/kg is administered.Investigators propose to compare the duration of caudal analgesia provided by plain ropivacaine and by a mixture of ropivacaine and S-ketamine.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Parallel AssignmentParallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
The Patients allocated to study groups using computer generates random list & group assignment is sealed in sequentially numbered opaque envelopes that open after induction of anesthesia.
Primary Purpose:
Treatment
Official Title:
Analgesic Effects of Caudal S-ketamine for Supplementation of Ropivacaine Caudal Analgesia in Children With Hypospadias
Anticipated Study Start Date :
Jun 20, 2023
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
May 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group S

the children are given a mixture of 0.2%ropivacaine 1 ml/kg and preservative-free S-ketamine 0.5 mg/kg for caudal analgesia.

Drug: S-ketamine & Ropivacaine
The experiment group (Group S) will receive a mixture of ropivacaine 0.2% 1 ml/kg and preservative-free S-ketamine 0.5 mg/kg caudally for postoperative analgesia.

Active Comparator: Group C

The children are given 0.2%ropivacaine 1 ml/kg and saline of equal volume caudally.

Drug: Ropivacaine
The experiment group (Group C) will receive ropivacaine 0.2% 1 ml/kg plain and equial volume saline caudally for postoperative analgesia.

Outcome Measures

Primary Outcome Measures

  1. duration of caudal analgesia [48 hours after the caudal injection]

    Duration of analgesia is defined as the time from caudal injection to the first need for systemic analgesia.

Secondary Outcome Measures

  1. Paracetamol consumption [48 hours after caudal block]

    Postoperative Pain Measure (PPPM) at 1 hour (h), 3h,6h,12h,24h,48h or the time when children complain of pain after surgery. A score of more than 6 points is taken as an indication of inadequate analgesia and paracetamol 15 mg/kg was administered .

  2. PPPM scores [48 hours after the caudal block]

    Postoperative Pain Measure (PPPM)

  3. complication [48 hours after the caudal block]

    the incidence of residual motor block, urinary retention, paraesthesia; the incidence of respiratory depression ,vomiting ,nystagmus ,odd behavior;.the sedation scores etc.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Months to 6 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • informed parent consent, ASA I or II children, between 3months and 6 years of age, scheduled for elective hypospadias surgery with general anesthesia will be recruited.
Exclusion Criteria:
  • Patients who have congenital abnormalities of lower spine and meninges.

  • Patients with hypersensitivity to any local anesthetics

  • Children with coagulation disorders

  • Presence of Infections at puncture sites

  • Preexisting neurological disease

  • Refusal to consent by parent/guardian

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Affiliated Hospital, Sun Yat-sen University Guangzhou Guangdong China 510000

Sponsors and Collaborators

  • Tao Zhang

Investigators

  • Study Chair: Tao Zhang, M.D., First Affiliated Hospital, Sun Yat-Sen University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Tao Zhang, Associate Professor, First Affiliated Hospital, Sun Yat-Sen University
ClinicalTrials.gov Identifier:
NCT05922605
Other Study ID Numbers:
  • Caudal S-ketamine
First Posted:
Jun 28, 2023
Last Update Posted:
Jun 28, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2023